AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. EFX
  4. [Form 4] Equifax, Incorporated Insider Trading Activity

[Form 4] Equifax, Incorporated Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Equifax insider sale by EVP/CFO/COO. John W. Gamble Jr., Equifax (EFX) executive, sold 3,000 shares of Common Stock on 08/18/2025 at $247.35 per share under a pre-established Rule 10b5-1 trading plan adopted 05/14/2025. After the sale he beneficially owns 62,202 shares, which figure includes accrued dividend equivalent units reinvested into restricted stock units through the company鈥檚 last dividend payment date. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 08/20/2025.

Vendita da insider di Equifax da parte di EVP/CFO/COO. John W. Gamble Jr., dirigente di Equifax (EFX), ha venduto 3.000 azioni ordinarie il 18/08/2025 a 247,35 USD per azione nell鈥檃mbito di un piano di negoziazione Rule 10b5-1 preesistente adottato il 14/05/2025. Dopo la vendita detiene beneficiariamente 62.202 azioni, cifra che include unit脿 equivalenti di dividendo maturate reinvestite in restricted stock units fino all鈥檜ltima data di pagamento dei dividendi della societ脿. Il Modulo 4 猫 stato firmato per conto del dichiarante da una persona munita di procura il 20/08/2025.

Venta de insider de Equifax por EVP/CFO/COO. John W. Gamble Jr., ejecutivo de Equifax (EFX), vendi贸 3.000 acciones ordinarias el 18/08/2025 a 247,35 USD por acci贸n bajo un plan de negociaci贸n Rule 10b5-1 preestablecido adoptado el 14/05/2025. Tras la venta posee beneficiariamente 62.202 acciones, cifra que incluye unidades equivalentes de dividendo devengadas reinvertidas en restricted stock units hasta la 煤ltima fecha de pago de dividendos de la compa帽铆a. El Formulario 4 fue firmado en nombre del declarante por un apoderado el 20/08/2025.

Equifax 雮措秬鞛� 毵る弰 鈥� EVP/CFO/COO. Equifax (EFX) 鞛勳洂 John W. Gamble Jr.電� 2025-08-18鞐� 靷爠 靹れ爼霅� Rule 10b5-1 瓯半灅瓿勴殟(2025-05-14 毂勴儩)鞐� 霐半澕 氤错喌欤� 3,000欤茧ゼ 欤茧嫻 247.35雼煬鞐� 毵る弰頄堨姷雼堧嫟. 毵る弰 頉� 攴鸽姅 鞁れ鞝侅溂搿� 62,202欤茧ゼ 氤挫湢頃橁碃 鞛堨溂氅�, 鞚� 靾橃箻鞐愲姅 須岇偓鞚� 斓滉芳 氚半嫻 歆�旮夓澕鞚� 旮办鞙茧 鞛埇鞛愲悳 氚半嫻 霌标皜 雼渼臧� 鞝滍暅欤检嫕 雼渼搿� 韽暔霅橃柎 鞛堨姷雼堧嫟. Form 4電� 2025-08-20鞐� 氤搓碃鞛愳潣 雽�毽澑(鞙勳瀯鞛�)鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�.

Vente d'initi茅 d'Equifax par EVP/CFO/COO. John W. Gamble Jr., cadre d'Equifax (EFX), a vendu 3 000 actions ordinaires le 18/08/2025 脿 247,35 USD par action dans le cadre d'un plan de n茅gociation Rule 10b5-1 pr茅茅tabli adopt茅 le 14/05/2025. Apr猫s la vente, il d茅tient 脿 titre b茅n茅ficiaire 62 202 actions, chiffre qui inclut des unit茅s 茅quivalentes de dividende acquises et r茅investies en restricted stock units jusqu'脿 la derni猫re date de paiement des dividendes de la soci茅t茅. Le formulaire 4 a 茅t茅 sign茅 au nom de la personne d茅clarante par un mandataire le 20/08/2025.

Insider-Verkauf bei Equifax durch EVP/CFO/COO. John W. Gamble Jr., F眉hrungskraft bei Equifax (EFX), verkaufte am 18.08.2025 3.000 Stammaktien zu 247,35 USD je Aktie im Rahmen eines vorab festgelegten Rule鈥�10b5鈥�1鈥慔andelsplans, der am 14.05.2025 angenommen wurde. Nach dem Verkauf besitzt er wirtschaftlich 62.202 Aktien; diese Zahl umfasst angefallene Dividendengleichheits鈥慐inheiten, die bis zum letzten Dividendenzahlungstag des Unternehmens in Restricted Stock Units reinvestiert wurden. Das Formular 4 wurde am 20.08.2025 im Namen der meldenden Person von einem Bevollm盲chtigten unterzeichnet.

Positive
  • Sale executed under a Rule 10b5-1 trading plan, indicating the transaction was pre-planned
  • Clear disclosure of post-transaction beneficial ownership (62,202 shares) including reinvested dividend equivalents
Negative
  • Insider disposed of 3,000 shares, reducing direct holdings by that amount
  • Form 4 does not state proceeds or purpose of sale, limiting context for investors

Insights

TL;DR: Routine, pre-planned insider sale under a 10b5-1 plan; not an unplanned red flag.

The filing documents a planned disposition executed under a Rule 10b5-1 plan adopted on 05/14/2025, which provides the reporting person an affirmative defense against insider trading claims for transactions made pursuant to the plan. The disclosure lists the executive role (EVP, CFO & COO) and shows retained beneficial ownership of 62,202 shares including reinvested dividend equivalents. From a governance perspective, use of a 10b5-1 plan signals structured selling rather than opportunistic trading, but investors may note the timing and size relative to overall holdings.

TL;DR: Small, disclosed sale; limited market or valuation impact based on disclosed amounts.

The transaction is a sale of 3,000 shares at $247.35 each on 08/18/2025. Proceeds implied by the reported price are calculable from the disclosed quantity and price, but the filing does not provide proceeds or tax/vesting details. The report confirms continuing beneficial ownership of 62,202 shares. This is a straightforward insider sale disclosure without accompanying commentary on company performance or material events.

Vendita da insider di Equifax da parte di EVP/CFO/COO. John W. Gamble Jr., dirigente di Equifax (EFX), ha venduto 3.000 azioni ordinarie il 18/08/2025 a 247,35 USD per azione nell鈥檃mbito di un piano di negoziazione Rule 10b5-1 preesistente adottato il 14/05/2025. Dopo la vendita detiene beneficiariamente 62.202 azioni, cifra che include unit脿 equivalenti di dividendo maturate reinvestite in restricted stock units fino all鈥檜ltima data di pagamento dei dividendi della societ脿. Il Modulo 4 猫 stato firmato per conto del dichiarante da una persona munita di procura il 20/08/2025.

Venta de insider de Equifax por EVP/CFO/COO. John W. Gamble Jr., ejecutivo de Equifax (EFX), vendi贸 3.000 acciones ordinarias el 18/08/2025 a 247,35 USD por acci贸n bajo un plan de negociaci贸n Rule 10b5-1 preestablecido adoptado el 14/05/2025. Tras la venta posee beneficiariamente 62.202 acciones, cifra que incluye unidades equivalentes de dividendo devengadas reinvertidas en restricted stock units hasta la 煤ltima fecha de pago de dividendos de la compa帽铆a. El Formulario 4 fue firmado en nombre del declarante por un apoderado el 20/08/2025.

Equifax 雮措秬鞛� 毵る弰 鈥� EVP/CFO/COO. Equifax (EFX) 鞛勳洂 John W. Gamble Jr.電� 2025-08-18鞐� 靷爠 靹れ爼霅� Rule 10b5-1 瓯半灅瓿勴殟(2025-05-14 毂勴儩)鞐� 霐半澕 氤错喌欤� 3,000欤茧ゼ 欤茧嫻 247.35雼煬鞐� 毵る弰頄堨姷雼堧嫟. 毵る弰 頉� 攴鸽姅 鞁れ鞝侅溂搿� 62,202欤茧ゼ 氤挫湢頃橁碃 鞛堨溂氅�, 鞚� 靾橃箻鞐愲姅 須岇偓鞚� 斓滉芳 氚半嫻 歆�旮夓澕鞚� 旮办鞙茧 鞛埇鞛愲悳 氚半嫻 霌标皜 雼渼臧� 鞝滍暅欤检嫕 雼渼搿� 韽暔霅橃柎 鞛堨姷雼堧嫟. Form 4電� 2025-08-20鞐� 氤搓碃鞛愳潣 雽�毽澑(鞙勳瀯鞛�)鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�.

Vente d'initi茅 d'Equifax par EVP/CFO/COO. John W. Gamble Jr., cadre d'Equifax (EFX), a vendu 3 000 actions ordinaires le 18/08/2025 脿 247,35 USD par action dans le cadre d'un plan de n茅gociation Rule 10b5-1 pr茅茅tabli adopt茅 le 14/05/2025. Apr猫s la vente, il d茅tient 脿 titre b茅n茅ficiaire 62 202 actions, chiffre qui inclut des unit茅s 茅quivalentes de dividende acquises et r茅investies en restricted stock units jusqu'脿 la derni猫re date de paiement des dividendes de la soci茅t茅. Le formulaire 4 a 茅t茅 sign茅 au nom de la personne d茅clarante par un mandataire le 20/08/2025.

Insider-Verkauf bei Equifax durch EVP/CFO/COO. John W. Gamble Jr., F眉hrungskraft bei Equifax (EFX), verkaufte am 18.08.2025 3.000 Stammaktien zu 247,35 USD je Aktie im Rahmen eines vorab festgelegten Rule鈥�10b5鈥�1鈥慔andelsplans, der am 14.05.2025 angenommen wurde. Nach dem Verkauf besitzt er wirtschaftlich 62.202 Aktien; diese Zahl umfasst angefallene Dividendengleichheits鈥慐inheiten, die bis zum letzten Dividendenzahlungstag des Unternehmens in Restricted Stock Units reinvestiert wurden. Das Formular 4 wurde am 20.08.2025 im Namen der meldenden Person von einem Bevollm盲chtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GAMBLE JOHN W JR
(Last) (First) (Middle)
1550 PEACHTREE STREET, N.W.
(Street)
ATLANTA GA 30309
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EQUIFAX INC [ EFX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, CFO & COO
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/18/2025 S(1) 3,000 D $247.35 62,202(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/14/2025.
2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
/s/Lisa Stockard as Attorney-in-Fact 08/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did Equifax (EFX) insider John W. Gamble Jr. report on Form 4?

The Form 4 reports that John W. Gamble Jr. sold 3,000 shares of Equifax common stock on 08/18/2025 at $247.35 per share.

Was the sale by the Equifax executive part of a Rule 10b5-1 plan?

Yes. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 05/14/2025.

How many Equifax shares does the reporting person own after the sale?

The filing shows beneficial ownership of 62,202 shares following the reported transaction, which includes accrued dividend equivalent units reinvested into restricted stock units.

What price was reported for the sale of EFX shares?

The reported sale price was $247.35 per share for the 3,000 shares sold.

Who signed the Form 4 filing for the Equifax reporting person?

The Form 4 was signed on behalf of the reporting person by Lisa Stockard as Attorney-in-Fact on 08/20/2025.
Stock EFX logo
Equifax Inc

NYSE:EFX

EFX Rankings

#429 Ranked by Market Cap
#2105 Ranked by Dividends

EFX Latest News

Aug 20, 2025
Equifax Board of Directors Declares Quarterly Dividend
Aug 18, 2025
Technology Automation is a Top Challenge for Half of HR Professionals, Equifax Survey Finds
Jul 30, 2025
Equifax National Market Pulse Data Shows U.S. Consumers Continuing to Spend, Avoiding Delinquency
Jul 28, 2025
Equifax and Qlarifi Partner to Study Impact of Buy Now, Pay Later on Credit Risk and Fraud
Jul 22, 2025
Equifax Delivers Above Guidance Second Quarter Results; Returns Approximately $190 Million Cash to Shareholders

EFX Latest SEC Filings

Aug 20, 2025
[144] Equifax, Incorporated SEC Filing
Aug 18, 2025
[144] Equifax, Incorporated SEC Filing
Jul 30, 2025
[Form 4] Equifax, Incorporated Insider Trading Activity
Jul 28, 2025
[144] Equifax, Incorporated SEC Filing
Jul 22, 2025
[10-Q] Equifax, Incorporated Quarterly Earnings Report

EFX Stock Data

30.26B
123.10M
0.52%
98.02%
2.29%
Consulting Services
Services-consumer Credit Reporting, Collection Agencies
United States
ATLANTA